James Gilmore III, Insider at BARR PHARMACEUTICALS INC (BRL), sold 6,399 shares at $65.12 ($417K) on 2008-12-16, disclosed to the SEC on 2008-12-18.
Open-market sale of $417k BRL by Insider. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.11 | 200 | $13K | 3.1% |
| 2 | $65.11 | 1,600 | $104K | 25.0% |
| 3 | $65.12 | 300 | $20K | 4.7% |
| 4 | $65.12 | 400 | $26K | 6.2% |
| 5 | $65.14 | 200 | $13K | 3.1% |
| 6 | $65.15 | 500 |
| $33K |
| 7.8% |
| 7 | $65.16 | 500 | $33K | 7.8% |
| 8 | $65.17 | 100 | $7K | 1.6% |
| 9 | $65.17 | 500 | $33K | 7.8% |
| 10 | $65.18 | 500 | $33K | 7.8% |
| 11 | $65.19 | 300 | $20K | 4.7% |
| 12 | $65.19 | 100 | $7K | 1.6% |
| 13 | $65.21 | 100 | $7K | 1.6% |
| 14 | $65.24 | 300 | $20K | 4.7% |
| 15 | $65.25 | 300 | $20K | 4.7% |
| 16 | $65.26 | 99 | $6K | 1.5% |
| 17 | $65.26 | 200 | $13K | 3.1% |
| 18 | $65.27 | 100 | $7K | 1.6% |
| 19 | $69.10 | 100 | $7K | 1.7% |
| Total | $65.22 avg | 6,399 | $417K | 100% |
| Filing → |
| AAWW | SELL | 2017-03-01 | $447K | — | Filing → |
| CACI | SELL | 2011-03-15 | $12K | — | Filing → |
| CACI | SELL | 2010-12-02 | $17K | — | Filing → |